Aisling Capital Management as of Dec. 31, 2018
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 12 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Obseva Sa | 18.5 | $18M | 1.4M | 12.66 | |
| Eidos Therapeutics | 16.3 | $16M | 1.1M | 13.76 | |
| Avrobio Ord (AVRO) | 12.9 | $12M | 737k | 16.65 | |
| Marker Therapeutics Ord | 11.7 | $11M | 2.0M | 5.55 | |
| Biohaven Pharmaceutical Holding | 10.7 | $10M | 275k | 36.98 | |
| Aeglea Biotherapeutics | 6.8 | $6.5M | 869k | 7.49 | |
| Arcus Biosciences Incorporated (RCUS) | 6.1 | $5.8M | 537k | 10.77 | |
| Aclaris Therapeutics (ACRS) | 4.9 | $4.7M | 635k | 7.39 | |
| Verona Pharma Plc ads (VRNA) | 4.5 | $4.3M | 444k | 9.65 | |
| Zosano Pharma Corp | 3.6 | $3.4M | 1.6M | 2.12 | |
| Nabriva Therapeutics | 2.8 | $2.6M | 1.8M | 1.46 | |
| Sunesis Pharmaceuticals Inc Ne | 1.1 | $1.1M | 2.6M | 0.42 |
